NIAID Virology Quality Assurance
ID: 75N93024R00030Type: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH NIAIDBETHESDA, MD, 20892, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (AN12)

Original Source

https://sam.gov/opp/cdaa950ec1f241c3b8d860a5b2163b27/view
Timeline
    Description

    The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting proposals for the Virology Quality Assurance (VQA) program under RFP number 75N93024R00030, aimed at enhancing quality assessment for virologic testing in clinical trials related to HIV and other viral pathogens. The program requires contractors to provide comprehensive quality assurance services, including performance validation reports and progress updates, while adhering to strict federal regulations and ethical standards concerning human subjects in research. This initiative is critical for establishing robust quality controls in virology testing, thereby supporting public health responses and ongoing research efforts. Proposals are due by April 8, 2025, at 3:00 PM EST, and interested parties should direct inquiries to Shawnice Williams at shawnice.williams@nih.gov or Ashley Kinderdine at ashley.kinderdine@nih.gov for further clarification.

    Point(s) of Contact
    Shawnice Williams
    (301) 761-5431
    shawnice.williams@nih.gov
    Ashley Kinderdine
    (240) 669-5154
    ashley.kinderdine@nih.gov
    Files
    Title
    Posted
    Amendment 1 RFP 75N93024R00030.pdf
    The document is an amendment to RFP No. 75N93024R00030 for the "NIAID Virology Quality Assurance," issued by NIAID under the NIH. The amendment, dated January 13, 2025, does not alter the proposal due date of April 8, 2025, and adds seven attachments, detailing the requirements for submitting proposals electronically. The main focus of the RFP is to solicit proposals for laboratory quality assurance programs for virologic assays related to HIV and other viral pathogens, ensuring accurate lab performance through proficiency testing and real-time validation controls. The Statement of Work (SOW) delineates responsibilities for conducting rigorous quality assessments, including the implementation of performance standards, statistical evaluations, and the maintenance of quality control materials. The contractor must navigate regulatory responsibilities, manage donor programs, and maintain a donor pool for acquiring necessary biological samples while ensuring compliance with ethical standards. Furthermore, provisions are made for potential contract extensions and increases in scope to cater to emerging healthcare challenges. This solicitation underscores NIAID's commitment to enhancing lab capabilities in virology for clinical applications while supporting ongoing research and public health responses.
    Amendment 2 RFP 75N93024R00030.pdf
    Amendment #2 to RFP No. 75N93024R00030 pertains to the “NIAID Virology Quality Assurance” project, issued by the National Institute of Allergy and Infectious Diseases (NIAID). The amendment, dated March 7, 2025, maintains the proposal due date of April 8, 2025, at 3:00 PM EST. Key modifications include updates to Article B.4 regarding the System for Award Management (SAM) statements, clarification on shipping and packaging cost assumptions, and the inclusion of an updated FAR clause (52.204-8) related to annual representations and certifications. Notably, Section 3.3 on shipping and packaging is clarified to indicate that it does not add to the work's shipping costs but is part of a breakdown. Offerors are required to acknowledge receipt of this amendment in their proposals, and all other solicitation terms remain unchanged. This amendment emphasizes the federal government's ongoing efforts to refine proposal processes and ensure clarity for potential bidders involved in government contracting.
    Sol_75N93024R00030.pdf
    The National Institute of Allergy and Infectious Diseases (NIAID) is soliciting proposals for the Virology Quality Assurance (VQA) program under RFP number 75N93024R00030, issued on January 8, 2025, with a proposal deadline set for April 8, 2025. The program aims to provide comprehensive quality assessment for virologic testing in clinical trials related to HIV and other viral pathogens. Proposals must adhere to strict submission guidelines and address various deliverables, including performance validation reports and progress updates throughout the contract period. The contract includes options for increased support in response to public health emergencies and additional laboratory demands. Key requirements also emphasize confidentiality, adherence to federal regulations, and compliance with the protection of human subjects in research. The contractor must ensure proper reporting and invoicing practices within the prescribed frameworks outlined in the solicitation. This initiative highlights the government's commitment to establishing robust quality controls in virology testing while facilitating collaborations across health agencies. Stakeholders are encouraged to direct questions to the contract specialist prior to the deadline.
    Lifecycle
    Title
    Type
    NIAID Virology Quality Assurance
    Solicitation
    NIAID Virology Quality Assurance
    Presolicitation
    NIAID Virology Quality Assurance
    Currently viewing
    Sources Sought
    Similar Opportunities
    Serological Assays for the Detection and Characterization of Influenza Viruses
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Centers for Disease Control and Prevention (CDC), is seeking proposals for "Serological Assays for the Detection and Characterization of Influenza Viruses." The procurement aims to secure services for performing Hemagglutinin Inhibition (HAI) assays on approximately 6,000 human samples annually, with the potential for surge support up to 10,500 tests, alongside the development of new high-throughput serology assays. This initiative is crucial for enhancing the CDC's capabilities in monitoring and responding to influenza outbreaks. Interested parties should note that the solicitation has been reopened, with key deadlines extended, and are encouraged to contact Jennifer Gartzke at jgartzke@cdc.gov for contractual inquiries. The contract will span a base period of 12 months with four additional option years, and all work must comply with Section 508 accessibility standards.
    Q301--Biodesix, Inc. (621 II) (PENDING PROPOSAL)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for reference laboratory services under the Federal Supply Schedule (FSS) program, specifically for medical laboratory testing related to the diagnosis, prevention, or treatment of diseases. The procurement aims to establish contracts for domestic delivery of medical laboratory services, ensuring compliance with all relevant state, federal, and local regulations, including necessary licenses and permits for testing services. This opportunity is critical for enhancing patient care through accurate diagnostic testing, with the expectation that offerors will provide new items only, adhering to FDA regulatory requirements. Interested vendors can contact the FSS Help Desk at Fss.Help@va.gov or call 708-786-7737 for further details, as the solicitation is currently pending and specific deadlines for proposal submissions will be outlined in the official solicitation documents.
    R499--Sterile Compounding Compliance QA Program
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through the Network Contracting Office 17, is seeking proposals for a Sterile Compounding Compliance Quality Assurance Program, specifically set aside for Service-Disabled Veteran-Owned Small Businesses (SDVOSB). This program encompasses a range of services, including monthly garbing competency assessments, media fill tests, hazardous drug manipulation competency evaluations, and cleaning and disinfection competency checks, with a contract period extending from January 1, 2026, to December 31, 2030. The importance of this procurement lies in ensuring compliance and safety in sterile compounding practices, which are critical for patient care in healthcare settings. Interested parties must submit their proposals by December 5, 2025, at 12 PM CST, and can direct inquiries to Contracting Specialist Matt Lee at matthew.lee5@va.gov or by phone at 210-393-9281.
    All Sites Primary Barrier Equipment and Decontamination Services
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking proposals for a firm-fixed price contract to provide All Sites Primary Barrier Equipment and Decontamination Services across various NIH locations, including the main campus in Bethesda, MD, and the NIAID Integrated Research Facility in Fort Detrick, MD. The contract aims to support the NIH's comprehensive safety program by ensuring the maintenance and decontamination of equipment used in high-level biosafety laboratories, which is crucial for maintaining a safe environment for research activities. Interested small businesses must submit their proposals by the due date of December 26, 2025, and can direct inquiries to primary contact Evguenia Mathur at jane.mathur@nih.gov or secondary contact Ashley Kinderdine at ashley.kinderdine@nih.gov for further clarification.
    Q301--Metabolomics and Lipidomics Pulmonary Study
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for a Metabolomics and Lipidomics Pulmonary Study, focusing on the analysis of 185 human samples. This contract, designated for Small Businesses under NAICS code 541714, aims to enhance understanding of pulmonary conditions through advanced biochemical analysis. The performance period for the contract is set from December 31, 2025, to December 30, 2026, with proposals due by December 15, 2025, at 10:00 AM MST. Interested vendors should direct inquiries to Contract Specialist Felicia L. Simpson at felicia.simpson@va.gov and ensure compliance with all registration and documentation requirements to facilitate timely processing.
    Inflammatory and Vascular Diseases Scientific Support
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a contract for Inflammatory and Vascular Diseases Scientific Support to Exonova Biosciences. The procurement aims to secure the services of a highly qualified scientist with extensive expertise in immunology and hereditary autoinflammatory diseases, who will contribute to the NIH's Biomedical and Metabolic Imaging Branch's research initiatives. This contract is crucial for advancing understanding in the fields of inflammation and vascular biology, particularly in relation to metabolic disorders, and is set to commence on January 1, 2026, with a performance period extending through December 31, 2026. Interested parties must respond by December 15, 2025, and can direct inquiries to Kimesha Leake at Kimesha.leake@nih.gov.
    Assay Development for Superior Understanding of Response and Efficacy (ASSURE)
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the Office of Assistant Secretary for Preparedness and Response (ASPR BARDA), is soliciting proposals for the ASSURE program, which focuses on the development of innovative assays to evaluate immune responses to infections and vaccinations. The primary objective is to create multiplexed, high-throughput, scalable, and sample-sparing assays that can assess immune status in response to chemical, biological, radiological, and nuclear (CBRN) threats, pandemic influenza, and other emerging infectious diseases. Approximately $8 million is available for four to five awards, with proposals evaluated based on technical approach, relevant experience, and cost reasonableness. Interested parties must submit an abstract by December 18, 2025, and can contact Rebecca Harmon at rebecca.harmon@ati.org or 843.760.3358 for further information.
    Quality Assurance Quality Control
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to procure Quality Assurance and Quality Control (QAQC) services through a federal contract valued at $4,997,532. This procurement is justified under FAR 6.302-5, which allows for actions authorized or required by statute, indicating the critical nature of the services being sought. The QAQC services are essential for ensuring compliance and quality in various programs managed by the department, particularly in the context of supporting veterans' services. Interested parties can reach out to Alanna Wilson at Alanna.Wilson@va.gov or by phone at 240-215-1633 for further details regarding this opportunity.
    R--RADx Award Management
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking sources for the RADx Award Management through a Special Notice. This procurement aims to identify qualified entities that can provide management consulting services related to the RADx initiative, which is crucial for enhancing COVID-19 testing capabilities and supporting public health efforts. Interested parties are encouraged to reach out to Melanie D. Suarez at melanie.suarez@nih.gov or call +1 301 827 7558 for further information regarding this opportunity. The notice emphasizes the importance of professional program management and support services in achieving the objectives of the RADx program.
    Distribution of Biorad Bioplex Reagents and Consumables for Laboratory Tests.
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 20, is seeking a qualified contractor for a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract focused on the distribution of BioRad BioPlex reagents and consumables for laboratory tests at the Seattle VA Medical Center. The contractor will be responsible for supplying FDA-approved equipment, reagents, controls, calibrators, and all necessary consumables, along with installation, validation, technical support, preventative maintenance, and staff training, ensuring compliance with specific performance requirements such as rapid analysis and automated calibration. This procurement is critical for enhancing patient care through immunoassays that diagnose various health conditions, including infectious diseases and autoimmune disorders. Quotes are due by December 19, 2025, at 17:00 Pacific Time, and interested parties can contact Hector Gonzalez at hector.gonzalez1@va.gov or by phone at 360-553-7632 for further information.